The FDA may require weight-loss drugs to undergo clinical trials to see if they pose a risk of heart attack.
The Scientist
Most Recent
Pathogens lurk in illegal wildlife products confiscated at US airports.
Early exposure to microbes shapes the mammalian immune system by subduing inflammatory T cells.
Are donors of biological material privy to research results that stem from their donation?
Should the healthcare system support health and wellness data tracking for the purposes of long-term observational studies?
Replacing immune cells in a mouse model of Rett syndrome, a developmental brain disorder, improved symptoms, suggesting a new target for treatment.
Anonymous letters to The Lancet point to problems with the CDC's Center for Global Health, but the agency denies the allegations.
One biopsy may not provide enough information about the array of mutations in cancer to devise treatments based on a tumor’s genetic profile.
A new method for transplanting immunologically mismatched organs may remove the need for life-long immunosuppressive drugs to prevent rejection.
NSABB and Congress members voice their opinions about the new developments in the H5N1 research debate.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
